Collins Kathryn K, Thiagarajan Ravi R, Chin Clifford, Dubin Anne M, Van Hare George F, Robbins Robert C, Mayer John E, Bernstein Daniel, Berul Charles I, Blume Elizabeth D
Pediatric Arrhythmia Center, University of California-San Francisco, San Francisco, CA, USA.
J Heart Lung Transplant. 2003 Oct;22(10):1126-33. doi: 10.1016/s1053-2498(02)01193-2.
Atrial tachyarrhythmias have been reported in as high as 50% of adult heart recipients. Limited information is available on arrhythmias in pediatric transplant patients. Our objective was to determine the prevalence and significance of atrial tachyarrhythmias and permanent pacing following pediatric heart transplantation.
A retrospective review of the medical records, electrocardiograms, and Holter recordings of all consecutive patients following heart transplantation at Children's Hospital, Boston (n = 104) and Lucile Packard Children's Hospital, Stanford (n = 123) was performed. The study group consisted of 227 patients with a median age at transplant of 10.2 yrs (1 day-23.3 yrs).
Atrial tachyarrhythmias occurred in 32 patients (14%) at a median of 15 days post-transplant (1 day-9.2 yrs) and included atrial flutter (n = 13), atrial fibrillation (n = 7), ectopic atrial tachycardia (n = 5), atrioventricular reciprocating tachycardia or atrioventricular node reentry (n = 5), and other (n = 2). Atrial flutter was the only tachyarrhythmia associated with allograft rejection (6/13 atrial flutter vs. 0/7 atrial fibrillation vs. 0/5 ectopic atrial tachycardia, p = 0.03). Patients with atrial fibrillation had a 2.5 fold (95%CI 1.7-3.5) higher risk of death or retransplant compared to patients without atrial fibrillation. Ectopic atrial tachycardia tended to occur in younger recipients compared to atrial fibrillation and flutter (2.7 yrs vs 18.6 yrs and 8.5 yrs respectively, p = 0.06) and was associated with a benign clinical course. There was no association between atrial tachyarrhythmias and graft ischemic time, surgical technique, or coronary artery disease. Pacemakers were required in 12 patients (5.2%), 7 with sinus node dysfunction and 5 for intermittent complete atrioventricular block. There was no consistent association between the need for permanent pacing and coronary artery disease, rejection, or surgical technique.
Atrial tachyarrhythmias and permanent pacing were uncommon in this cohort of pediatric heart transplant recipients. Association with cardiac rejection, clinical course, and mortality varied depending on the tachyarrhythmia mechanism.
据报道,高达50%的成年心脏移植受者会出现房性快速性心律失常。关于小儿移植患者心律失常的信息有限。我们的目的是确定小儿心脏移植术后房性快速性心律失常和永久性起搏的发生率及意义。
对波士顿儿童医院(n = 104)和斯坦福大学露西尔·帕卡德儿童医院(n = 123)所有连续心脏移植患者的病历、心电图和动态心电图记录进行回顾性分析。研究组包括227例患者,移植时的中位年龄为10.2岁(1天至23.3岁)。
32例患者(14%)出现房性快速性心律失常,中位发生时间为移植后15天(1天至9.2年),包括心房扑动(n = 13)、心房颤动(n = 7)、异位房性心动过速(n = 5)、房室折返性心动过速或房室结折返性心动过速(n = 5)以及其他类型(n = 2)。心房扑动是唯一与移植排斥相关的快速性心律失常(13例心房扑动中有6例,7例心房颤动和5例异位房性心动过速中均无,p = 0.03)。与无房颤患者相比,房颤患者死亡或再次移植的风险高2.5倍(95%可信区间1.7 - 3.5)。与心房颤动和心房扑动相比,异位房性心动过速倾向于发生在年龄较小的受者中(分别为2.7岁、18.6岁和8.5岁,p = 0.06),且临床病程良性。房性快速性心律失常与移植心脏缺血时间、手术技术或冠状动脉疾病之间无关联。12例患者(5.2%)需要植入起搏器,7例为窦房结功能障碍,5例为间歇性完全性房室传导阻滞。永久性起搏的需求与冠状动脉疾病、排斥反应或手术技术之间无一致关联。
在这组小儿心脏移植受者中,房性快速性心律失常和永久性起搏并不常见。根据快速性心律失常的机制,其与心脏排斥、临床病程和死亡率的关联各不相同。